Dr Jeremy Welton
Honorary (Fellow)
Department of Medicine
25 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
RWD261 MYASTHENIA GRAVIS HEALTHCARE RESOURCE USE AND COST OF THERAPY IN AUSTRALIA
DOI: 10.1016/j.vhri.2025.1014112025
Conference Proceedings
3457 A stratified analysis of efficacy and safety of fenfluramine in patients with dravet syndrome
DOI: 10.1136/bmjno-2025-anzan.462024
Conference Proceedings
2999 Response to rozanolixizumab across treatment cycles in patients with generalised myasthenia gravis: a post hoc analysis
DOI: 10.1136/bmjno-2024-anzan.362023
Conference Proceedings
2634 Cyclical rozanolixizumab treatment in generalised myasthenia gravis (gMG): pooled analysis of MycarinG (Phase 3 study) and two open-label extension studies
DOI: 10.1136/bmjno-2023-anzan.652023
Conference Proceedings
2628 12-Month effectiveness and tolerability of brivaracetam in the real-world in the international EXPERIENCE pooled analysis: final results and Australian subgroup
DOI: 10.1136/bmjno-2023-anzan.622023
Journal article
Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting
DOI: 10.1016/j.yebeh.2023.1091452021
Conference Proceedings
Antiseizure medication shortages are associated with increased product switching: an analysis of levetiracetam
RECENT SCHOLARLY WORKS
2021
Conference Proceedings
Shortages of oral antiseizure medications and estimation of the number of patients impacted by shortages in Australia
2021
Conference Proceedings
Brand switching of antiseizure medications and changes in adherence: an analysis of levetiracetam
2020
Journal article
Quality of life and its association with comorbidities and adverse events from antiepileptic medications: Online survey of patients with epilepsy in Australia
DOI: 10.1016/j.yebeh.2019.106856